BIO-11006

DRUG2 trials

Sponsors

BioMarck Pharmaceuticals, Ltd.

Conditions

COPDChronic Obstructive Pulmonary DiseaseRespiratory Distress Syndrome, Adult

Phase 2

Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD

CompletedNCT00648245

BioMarck Pharmaceuticals, Ltd.Chronic Obstructive Pulmonary Disease, COPD

Start: 2008-06-30End: 2010-07-31Target: 172Updated: 2011-02-10

Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS

CompletedNCT03202394

BioMarck Pharmaceuticals, Ltd.Respiratory Distress Syndrome, Adult

Start: 2017-08-05End: 2020-06-15Updated: 2020-06-25